Published in Arch Neurol on November 01, 1965
Measurement of tissue impedence in conjunction with computed tomography-guided stereotaxic biopsies. J Neurol Neurosurg Psychiatry (1987) 0.75
Pitfalls in precision stereotactic surgery. Surg Neurol Int (2012) 0.75
Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest (1985) 3.40
Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science (1979) 3.32
Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study. J Clin Oncol (1999) 2.25
Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity. J Immunol (2000) 2.06
Maculopathy from handheld diode laser pointer. Arch Ophthalmol (1999) 2.03
Behavioral effects of selective ablation of the caudate nucleus. J Comp Physiol Psychol (1967) 1.74
Serologic responses in patients with malignant mesothelioma: evidence for both public and private specificities. Am J Respir Cell Mol Biol (2000) 1.62
Extraction of immune and inflammatory cells from human lung parenchyma: evaluation of an enzymatic digestion procedure. Clin Exp Immunol (1986) 1.57
Selective inhibition of T cell proliferation but not expression of effector function by human alveolar macrophages. Thorax (1997) 1.56
Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis. J Clin Invest (1985) 1.54
Localization of function within the dorsolateral prefrontal cortex of the rhesus monkey. Exp Neurol (1970) 1.48
The YY syndrome. Lancet (1968) 1.47
Tumor antigens are constitutively presented in the draining lymph nodes. J Immunol (1999) 1.38
Establishment of a murine model of malignant mesothelioma. Int J Cancer (1992) 1.35
Alveolar macrophages from humans and rodents selectively inhibit T-cell proliferation but permit T-cell activation and cytokine secretion. Immunology (1995) 1.34
Genetic 'risk' for atopy is associated with delayed postnatal maturation of T-cell competence. Clin Exp Allergy (1992) 1.33
T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors. Cancer Res (1999) 1.28
Responses of units of the inferior colliculus to time-varying acoustic stimuli. J Neurophysiol (1966) 1.23
Alimentary responses to forebrain stimulation in monkeys. Exp Brain Res (1968) 1.20
Benign asbestos pleural effusion: diagnosis and course. Thorax (1981) 1.17
Natural killer cells are present in the normal human lung but are functionally impotent. J Clin Invest (1984) 1.11
Myocardial metastasis from carcinoma of pancreas presenting as acute myocardial infarction. J R Soc Med (1982) 1.09
Sex-dependent behavioral effects of cerebral cortical lesions in the developing rhesus monkey. Science (1974) 1.07
Analysis of the delayed-alternation deficit produced by dorsolateral prefrontal lesions in the rhesus monkey. J Comp Physiol Psychol (1971) 1.05
Arachnoid cysts of the middle cranial fossa: surgical considerations. Surg Neurol (1978) 1.05
Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusions. Int J Cancer (1991) 1.02
Functional analysis of human bronchial mucosal T cells extracted with interleukin-2. Am J Respir Crit Care Med (1994) 0.95
Transforming growth factor-beta: antisense RNA-mediated inhibition affects anchorage-independent growth, tumorigenicity and tumor-infiltrating T-cells in malignant mesothelioma. Growth Factors (1994) 0.95
Generation of an antitumour immune response to a murine mesothelioma cell line by the transfection of allogeneic MHC genes. Int J Cancer (1994) 0.93
The effects of selective caudate lesions in infant and juvenile Rhesus monkeys. Brain Res (1972) 0.92
Correlation of epidermal growth factor receptor and c-erbB2 oncogene product to known prognostic indicators of colorectal cancer. Surg Oncol (1992) 0.92
The dentino-enamel junction: a structural and microanalytical study of early mineralization. Calcif Tissue Int (1989) 0.92
Spatial memory impairments following damage to the mediodorsal nucleus of the thalamus in rhesus monkeys. Brain Res (1982) 0.91
Neutrophil chemotactic factor release and neutrophil alveolitis in asbestos-exposed individuals. Chest (1988) 0.91
Alveolitis of pulmonary asbestosis. Bronchoalveolar lavage studies in crocidolite- and chrysotile-exposed individuals. Chest (1986) 0.91
Sera from patients with malignant mesothelioma can contain autoantibodies. Lung Cancer (1998) 0.90
Role of neutrophils in mediating human epithelial cell detachment from native basement membrane. J Allergy Clin Immunol (1995) 0.89
Intra-uterine healing of fetal rat cheek wounds. Cleft Palate J (1981) 0.89
A clonal analysis of lung T cells derived by bronchoalveolar lavage of healthy individuals. Immunology (1992) 0.88
Topographic projections on the globus pallidus and the substantia nigra of selectively placed lesions in the precommissural caudate nucleus and putamen in the monkey. Exp Neurol (1971) 0.88
Penile erection evoked from forebrain structures in Macaca mulatta. Arch Neurol (1968) 0.88
Evidence for behavioral impairment following prefrontal lobectomy in the infant monkey. J Comp Physiol Psychol (1970) 0.87
The immune anti-tumor effects of GM-CSF and B7-1 gene transfection are enhanced by surgical debulking of tumor. Cancer Gene Ther (2001) 0.87
Henoch-Schonlein purpura due to food sensitivity. Br Med J (1977) 0.87
The frontal lobe system: cortical-subcortical interrelationships. Acta Neurobiol Exp (Wars) (1972) 0.87
Interleukin-6 involvement in mesothelioma pathobiology: inhibition by interferon alpha immunotherapy. Cancer Immunol Immunother (1995) 0.86
Lysis of human malignant mesothelioma cells by natural killer (NK) and lymphokine-activated killer (LAK) cells. Am Rev Respir Dis (1989) 0.86
Nitrofurantoin-induced interstitial pulmonary fibrosis. Presentation and outcome. Med J Aust (1983) 0.86
Interleukin-12 induces an effective antitumor response in malignant mesothelioma. Am J Respir Cell Mol Biol (1998) 0.85
Effects of different density gradient separation techniques on neutrophil function. Scand J Clin Lab Invest (1994) 0.85
Asbestos fibres inhibit the in vitro activity of lymphokine-activated killer (LAK) cells from healthy individuals and patients with malignant mesothelioma. Clin Exp Immunol (1991) 0.85
Antisense oligonucleotides specific for transforming growth factor beta2 inhibit the growth of malignant mesothelioma both in vitro and in vivo. Cancer Res (1997) 0.84
Foraging performance of diet-induced morphotypes in pumpkinseed sunfish (Lepomis gibbosus) favours resource polymorphism. J Evol Biol (2007) 0.84
Epithelial cell damage is induced by neutrophil-derived, not pseudomonas-derived, proteases in cystic fibrosis sputum. Respir Med (1998) 0.84
Effect of interferon-alpha 2a on malignant mesothelioma. J Interferon Res (1993) 0.84
Heterospecific aggression and adaptive divergence in brook stickleback (Culaea inconstans). Evolution (2007) 0.84
Natural killer (NK)-resistant human lung cancer cells are lysed by recombinant interleukin-2-activated NK cells. Cell Immunol (1987) 0.83
Projections from behaviorally-defined sectors of the prefrontal cortex to the basal ganglia, septum, and diencephalon of the monkey. Exp Neurol (1968) 0.83
Comparison of bronchoalveolar lavage helper/suppressor T-cell ratios in sarcoidosis versus other interstitial lung diseases. Aust N Z J Med (1987) 0.83
Limbic influences on human speech. Ann N Y Acad Sci (1976) 0.83
Expression and immune recognition of stress proteins in sarcoidosis and other chronic interstitial lung diseases. Immunol Cell Biol (1995) 0.83
Pulmonary and meningeal cryptococcosis in pulmonary alveolar proteinosis. Aust N Z J Med (1999) 0.83
Dissociation of deficits on auditory tasks following partial prefrontal lesions in monkeys. Acta Neurobiol Exp (Wars) (1975) 0.83
Patho- and immunobiology of malignant mesothelioma: characterisation of tumour infiltrating leucocytes and cytokine production in a murine model. Cancer Immunol Immunother (1994) 0.83
Habituation: regulation through presynaptic inhibition. Science (1973) 0.82
Potential for cytokine therapy of malignant mesothelioma. Cancer Treat Rev (1995) 0.80
Private specificities can dominate the humoral response to self-antigens in patients with cryptogenic fibrosing alveolitis. Respir Res (2001) 0.80
Transfection of the gene for B7-1 but not B7-2 can induce immunity to murine malignant mesothelioma. Int J Cancer (1997) 0.80
Interferon alpha and doxorubicin in malignant mesothelioma: a phase II study. Aust N Z J Med (1993) 0.80
Delayed alternation in monkeys after removal of the hippocampus. Neuropsychologia (1970) 0.80
Potential for interferon-alpha-based therapy in mesothelioma: assessment in a murine model. J Interferon Cytokine Res (1995) 0.80
Cytokine gene therapy of mesothelioma. Immune and antitumor effects of transfected interleukin-12. Am J Respir Cell Mol Biol (1999) 0.80
Clonal analysis of lung and blood T cells in patients with sarcoidosis. Thorax (1994) 0.80
Intralesional cytokine therapy in cancer: a pilot study of GM-CSF infusion in mesothelioma. J Immunother (1998) 0.80
Malignant schwannoma with rapid progression: a case report. Australas Radiol (1985) 0.79
Altered CD3 chain and cytokine gene expression in tumor infiltrating T lymphocytes during the development of mesothelioma. Cancer Lett (1996) 0.79
Gallium lung scanning and bronchoalveolar lavage in crocidolite-exposed workers. Chest (1989) 0.79
p53 autoantibodies in patients with malignant mesothelioma: stability through disease progression. Br J Cancer (2001) 0.79
HLA antigen expression and malignant mesothelioma. Am J Respir Cell Mol Biol (1991) 0.79
Emerging translational therapies for mesothelioma. Chest (1999) 0.79
Malignant mesothelioma: new insights into tumour biology and immunology as a basis for new treatment approaches. Thorax (1995) 0.79
Delayed recovery of function following orbital prefrontal lesions in infant monkeys. Science (1973) 0.78
Chemosensitivity and cytokine sensitivity of malignant mesothelioma. Cancer Chemother Pharmacol (1991) 0.78
Subhuman primate-associated hepatitis. J Infect Dis (1975) 0.78
Visual discrimination in the monkey following serial ablation of inferotemporal and preoccipital cortex. J Comp Physiol Psychol (1968) 0.78
Asbestos-induced release of a human alveolar macrophage-derived neutrophil chemotactic factor. Exp Lung Res (1990) 0.78
Selective sparing of function following prefrontal lobectomy in infant monkeys. Exp Neurol (1970) 0.78
Relationships between current intensity, self-stimulation rates, escape latencies, and evoked behavior in rhesus monkeys. J Comp Physiol Psychol (1966) 0.78
Oral inverted ductal papilloma. Oral Surg Oral Med Oral Pathol (1984) 0.78
Study of human epithelial cell detachment and damage: development of a model. Immunol Cell Biol (1989) 0.78
Experimental and theoretical approaches to neural processing in the central auditory pathway. Contrib Sens Physiol (1968) 0.77
Simian virus (SV) 40 like sequences in cell lines and tumour biopsies from Australian malignant mesotheliomas. Aust N Z J Med (2000) 0.77
Effect of caudate and septal nuclei lesions on resistance to extinction and delayed-alternation. J Comp Physiol Psychol (1968) 0.77
A new statistical test of fitness set data from reciprocal transplant experiments involving intermediate phenotypes. Am Nat (2004) 0.77
Presynaptic inhibition: the mechanism of protection from habituation of the crayfish lateral giant fibre escape response. J Physiol (1977) 0.77
Defence, attack, and flight elicited by electrical stimulation of the hypothalamus of the cat. Exp Brain Res (1969) 0.77
Study of human epithelial cell detachment and damage: effects of proteases and oxidants. Immunol Cell Biol (1990) 0.77
Time discrimination with positional responses after selective prefrontal lesions in monkeys. Brain Res (1981) 0.76